| abstract |
The invention relates to compounds of Formula (1 ) and to intermediates in the preparation of, compositions containing and uses of such derivatives. The compounds according to the present invention are β2 adrenergic receptor agonists and M3 muscarine receptor antagonists useful in numerous diseases, disorder and conditions, in particular inflammatory, allergic and respiratory diseases, disorder and conditions. |